Posts

Scientists extract genetic secrets from 4,000-year-old ...

Researchers at Trinity College Dublin have recovered remarkably preserved microb...

World’s first demonstration that forests trap airborne ...

A research group led by Japan Women’s University finds that airborne microplasti...

What Bronze Age teeth say about the evolution of the hu...

A new paper in Molecular Biology and Evolution, published by Oxford Univeristy P...

Twist of groundwater contaminants

In recent years, the world has been experiencing floods and droughts as extreme ...

Scientists warn: The grey seal hunt is too large

Researchers at the University of Gothenburg warn that today’s hunting quotas of ...

Scientists discover how caterpillars can stop their ble...

Blood is a remarkable material: it must remain fluid inside blood vessels, yet c...

Spot-on laser treatment for skin blemishes becoming cle...

Many people bothered by skin blemishes might turn to laser treatment. To improve...

Johnson Matthey Sells Medical Metal Unit to Montagu in ...

Johnson Matthey, a British corporation specializing in metals and chemicals, is ...

FDA approves Takeda’s Iclusig for Philadelphia chromoso...

Twelve years after the FDA initially granted limited approval to Takeda’s Iclusi...

CRISPR-based assay could revolutionise diagnosis of NTM...

The CRISPR-based assay significantly accelerates the current diagnostic process,...

Esperion snags US label expansion for cardiovascular di...

Esperion Therapeutics’ Nexletol and Nexlizet are now available for patients with...

AriBio licenses Alzheimer’s pill in China for up to $770m

An unnamed Chinese partner takes on AR1001 in an APAC Alzheimer’s market predict...

Birmingham University to develop lollipop for mouth can...

The University of Birmingham has secured £350,000 in funding to develop a flavou...

Gilead acquires CymaBay Therapeutics for $4.3bn

Gilead Sciences has concluded the acquisition of CymaBay Therapeutics in a trans...

FDA approves J&J’s OPSYNVI for pulmonary arterial hyper...

The US FDA approved Johnson & Johnson's (J&J) OPSYNVI for chronic treatment in a...

Cancer Research UK and CRIS fund lung cancer vaccine re...

Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) g...